Antemortem tau positron emission tomography (PET) imaging suggests elevated tau pathology in autosomal dominant (ADAD) versus late‐onset Alzheimer’s disease (LOAD) at equivalent clinical stages. This evidence concerns the gene MAPT and Alzheimer disease.